December 20, 2007
UBS faces rebellion over fund injection (FT.com)
FT.com – UBS (NYSE:UBS), one of the biggest casualties of the US subprime turmoil, faces a shareholders’ revolt over plans for a massive infusion of funds from Singapore and the Middle East to improve its capital ratios.



